These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35348171)

  • 21. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity.
    Jozefíková F; Perontsis S; Koňáriková K; Švorc Ľ; Mazúr M; Psomas G; Moncol J
    J Inorg Biochem; 2022 Mar; 228():111696. PubMed ID: 35030390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodinated chlorin p
    Sarbadhikary P; Dube A
    Chem Biol Interact; 2017 Nov; 277():137-144. PubMed ID: 28918125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes.
    Barrett S; De Franco M; Kellett A; Dempsey E; Marzano C; Erxleben A; Gandin V; Montagner D
    J Biol Inorg Chem; 2020 Feb; 25(1):49-60. PubMed ID: 31655896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
    Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
    J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex.
    Flamme M; Cressey PB; Lu C; Bruno PM; Eskandari A; Hemann MT; Hogarth G; Suntharalingam K
    Chemistry; 2017 Jul; 23(40):9674-9682. PubMed ID: 28556445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
    Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
    Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Copper-Containing Cytotoxic Agents Based on 2-Thioxoimidazolones.
    Krasnovskaya OO; Guk DA; Naumov AE; Nikitina VN; Semkina AS; Vlasova KY; Pokrovsky V; Ryabaya OO; Karshieva SS; Skvortsov DA; Zhirkina IV; Shafikov RR; Gorelkin PV; Vaneev AN; Erofeev AS; Mazur DM; Tafeenko VA; Pergushov VI; Melnikov MY; Soldatov MA; Shapovalov VV; Soldatov AV; Akasov RA; Gerasimov VM; Sakharov DA; Moiseeva AA; Zyk NV; Beloglazkina EK; Majouga AG
    J Med Chem; 2020 Nov; 63(21):13031-13063. PubMed ID: 32985193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Discrete Breast Cancer Stem Cell Mammosphere Activity of Group 10-Bis(azadiphosphine) Metal Complexes.
    Xiao Z; Johnson A; Singh K; Suntharalingam K
    Angew Chem Int Ed Engl; 2021 Mar; 60(12):6704-6709. PubMed ID: 33274606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.
    Simunkova M; Barbierikova Z; Jomova K; Hudecova L; Lauro P; Alwasel SH; Alhazza I; Rhodes CJ; Valko M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
    Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II).
    Hasinoff BB; Yadav AA; Patel D; Wu X
    J Inorg Biochem; 2014 Aug; 137():22-30. PubMed ID: 24798374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition.
    Besleaga I; Stepanenko I; Petrasheuskaya TV; Darvasiova D; Breza M; Hammerstad M; Marć MA; Prado-Roller A; Spengler G; Popović-Bijelić A; Enyedy EA; Rapta P; Shutalev AD; Arion VB
    Inorg Chem; 2021 Aug; 60(15):11297-11319. PubMed ID: 34279079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studying the reactivity of "old" Cu(II) complexes for "novel" anticancer purposes.
    Peña Q; Lorenzo J; Sciortino G; Rodríguez-Calado S; Maréchal JD; Bayón P; Simaan AJ; Iranzo O; Capdevila M; Palacios Ò
    J Inorg Biochem; 2019 Jun; 195():51-60. PubMed ID: 30925401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
    Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
    J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
    Novohradsky V; Markova L; Kostrhunova H; Trávníček Z; Brabec V; Kasparkova J
    Sci Rep; 2019 Sep; 9(1):13327. PubMed ID: 31527683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
    Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
    Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.
    Yip NC; Fombon IS; Liu P; Brown S; Kannappan V; Armesilla AL; Xu B; Cassidy J; Darling JL; Wang W
    Br J Cancer; 2011 May; 104(10):1564-74. PubMed ID: 21487404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.